Abbott plans to appeal $1.67B patent order (San Francisco Chronicle)
Abbott plans to appeal $1.67B patent order (San Francisco Chronicle)
Abbott Laboratories plans to appeal a jury’s $1.67 billion patent infringement ruling in a case involving two blockbuster drugs that treat rheumatoid arthritis and other immune disorders. Late Monday, a jury in the Eastern District of Texas found that Abbott’… Sponsored Topics: Abbott Laboratories – United States District Court for the Eastern District of Texas – Patent infringement – …